influenza
infect
human
caus
wide
rang
diseas
symptom
asymptomat
seriou
ill
character
sudden
onset
fever
myalgia
respiratori
indic
includ
nonproduct
cough
sore
throat
rhiniti
addit
children
infect
influenza
commonli
present
otiti
media
nausea
vomit
frequent
complain
rhinorrhea
histor
pediatr
elderli
popul
consid
vulner
influenza
epidem
although
still
debat
studi
suggest
children
uniqu
role
spread
influenza
epidem
children
year
old
suscept
secondari
complic
infant
sever
respiratori
tract
viral
infect
often
greater
danger
pulmonari
dysfunct
includ
wheez
allergi
asthma
later
life
contrast
elderli
individu
higher
risk
develop
hemorrhag
bronchiti
pneumonia
death
infect
influenza
popul
gener
immun
respons
follow
influenza
immun
although
rsv
infect
lead
caus
hospit
children
unit
state
influenza
account
highest
incid
infect
children
year
age
influenza
epidem
occur
annual
caus
signific
morbid
mortal
worldwid
cdc
estim
unit
state
alon
annual
death
underli
pneumonia
influenza
caus
death
underli
respiratori
circulatori
caus
furthermor
individu
underli
respiratori
cardiac
diseas
diabet
melliti
infect
influenza
often
higher
risk
develop
hemorrhag
bronchiti
pneumonia
associ
comorbid
estim
death
attribut
influenza
children
year
age
global
develop
countri
carri
largest
burden
unit
state
annual
influenza
epidem
account
estim
billion
total
econom
burden
direct
medic
cost
estim
million
hospit
cost
children
introduct
influenza
human
popul
quickli
dissemin
global
caus
first
pandem
centuri
novel
viru
hereaft
refer
disproportion
affect
children
young
adult
observ
mortal
increas
four
time
pediatr
popul
initi
wave
infect
compar
previou
influenza
season
wherea
individu
born
prior
antibodi
result
within
popul
older
individu
year
wherea
year
old
risk
factor
sever
infect
similar
season
influenza
also
includ
obes
major
sever
fatal
case
accompani
chronic
ill
cardiac
diseas
chronic
respiratori
diseas
diabet
sever
studi
suggest
pregnant
postpartum
women
increas
risk
complic
infect
furthermor
sever
infect
relat
length
time
symptom
onset
initi
antivir
treatment
na
inhibitor
influenza
infect
associ
secondari
bacteri
infect
superinfect
notabl
streptococcu
pneumonia
staphylococcu
aureu
review
ref
children
common
secondari
bacteri
infect
lead
acut
otiti
media
found
patient
symptomat
influenza
infect
five
six
case
observ
annual
everi
children
year
age
sinc
emerg
approxim
fatal
infect
associ
bacteri
coinfect
number
includ
case
respiratori
support
need
ad
risk
secondari
infect
fatal
case
infect
diffus
alveolar
damag
alon
diffus
alveolar
damag
associ
necrot
bronchiol
diffus
alveolar
damag
hemorrhag
found
case
necrot
bronchiol
found
individu
bacteri
coinfect
vaccin
remain
effect
primari
prevent
strategi
avert
influenza
infect
world
health
organ
cdc
recommend
children
adult
age
month
receiv
influenza
vaccin
annual
current
three
licens
season
vaccin
administ
unit
state
tiv
administ
im
inject
laiv
deliv
intranas
tiv
prepar
includ
three
circul
strain
influenza
grown
egg
reflect
annual
surveil
data
predict
strain
b
like
circul
follow
season
northern
southern
hemispher
im
tiv
approv
use
children
adult
month
age
wherea
newer
id
tiv
approv
adult
age
year
laiv
approv
use
healthi
children
adult
year
age
current
influenza
vaccin
work
induc
memori
recal
respons
primarili
via
humor
immun
respons
ha
na
surfac
glycoprotein
ha
inhibit
antibodi
respons
follow
immun
correl
protect
infect
main
compon
standard
influenza
vaccin
ha
protein
safeti
trial
challeng
studi
amount
ha
within
vaccin
correl
level
protect
elicit
immun
begin
northern
influenza
season
vaccin
contain
havaccin
strain
oppos
prepar
approv
altern
tiv
elderli
individu
age
year
follow
vaccin
asc
rapidli
prolifer
upon
antigen
exposur
cell
number
peak
week
postimmun
healthi
adult
children
igg
iga
asc
declin
low
level
week
postimmun
increas
total
number
asc
correspond
nab
level
postvaccin
peak
week
adult
children
laiv
elicit
strong
serum
mucos
antibodi
respons
studi
young
children
month
age
show
receiv
laiv
significantli
reduc
incid
influenza
infect
although
limit
data
exist
asc
nab
titer
increas
greater
degre
follow
tiv
immun
compar
laiv
vaccin
role
neutral
laiv
occur
individu
well
understood
influenza
immun
effect
studi
healthi
children
year
age
shown
tiv
efficaci
rang
review
ref
sinc
univers
influenza
vaccin
recommend
ie
individu
least
month
age
tradit
effort
remain
focus
individu
greatest
risk
seriou
diseas
young
children
elderli
individu
pulmonari
cardiovascular
disord
immunocompromis
pregnant
vaccin
program
also
elicit
indirect
benefit
includ
herd
immun
immun
individu
protect
immunocompromis
nonvaccin
individu
effect
observ
retrospect
epidemiolog
studi
japan
unit
state
examin
mortal
influenza
vaccin
rate
children
long
consid
import
role
spread
influenza
epidem
japanes
offici
legisl
compulsori
vaccin
children
polici
chang
option
immun
becam
clear
mortal
rate
invers
correl
overal
vaccin
coverag
howev
recent
review
vaccin
studi
variou
popul
conclud
overestim
benefit
vaccin
common
particularli
within
elderli
popul
studi
take
account
select
bias
suggest
vaccin
associ
lower
risk
hospit
pneumonia
influenza
well
mortal
furthermor
octob
unit
state
commenc
nation
influenza
vaccin
campaign
estim
us
popul
receiv
influenza
vaccin
respect
follow
implement
campaign
frequenc
posit
influenza
cultur
report
cdc
declin
quickli
immun
herd
immun
result
prior
exposur
like
result
decreas
case
influenza
influenza
season
undoubtedli
influenza
vaccin
improv
particularli
vulner
popul
continu
epidemiolog
surveil
circul
influenza
strain
requir
keep
pace
antigen
drift
shift
review
ref
antigen
drift
endless
battl
wherebi
viral
variant
emerg
result
point
mutat
within
viral
genom
escap
viral
neutral
wherea
mani
mutat
occur
throughout
viral
genom
point
mutat
within
ha
na
protein
chang
domain
individu
longer
adequ
protect
b
cell
memori
respons
contrast
major
qualit
chang
antigen
result
antigen
shift
occur
result
genet
reassort
replac
one
influenza
gene
segment
turn
creat
new
influenza
viru
subtyp
littl
immun
may
exist
within
popul
antigen
shift
remain
chief
concern
highli
pathogen
influenza
virus
could
potenti
gain
effici
transmiss
influenza
virus
frequent
undergo
antigen
drift
less
frequent
shift
desir
vaccin
candid
would
abl
induc
highli
specif
antibodi
cell
respons
one
strategi
use
vaccin
improv
includ
use
adjuv
increas
antigen
uptak
apc
enhanc
cytokin
product
neither
tiv
laiv
includ
adjuv
sever
licens
vaccin
avail
outsid
unit
state
use
oil
water
emuls
season
influenza
well
review
ref
instanc
novarti
vaccin
diagnost
switzerland
manufactur
fluad
use
adjuv
glaxosmithklin
biolog
belgium
produc
pandemrix
includ
fluad
use
europ
sinc
recent
approv
use
canada
adult
year
older
surfact
includ
stabil
emuls
clinic
trial
vaccin
elicit
higher
antibodi
respons
adult
children
compar
unadjuv
vaccin
prepar
concept
univers
influenza
vaccin
one
vaccin
elicit
protect
multipl
influenza
subtyp
becom
realiti
influenza
ion
channel
express
high
level
surfac
cell
conserv
ectodomain
aa
length
anim
studi
demonstr
improv
viral
clearanc
upon
lethal
challeng
mice
follow
passiv
mab
transfer
mice
review
ref
phase
clinic
safeti
trial
evalu
manufactur
vaxinn
report
increas
antibodi
respons
creation
univers
influenza
vaccin
target
conserv
region
ha
stem
region
particularli
appeal
sever
group
demonstr
encourag
result
use
broadli
neutral
mab
region
ha
group
group
influenza
strain
structur
analys
indic
antibodi
bind
conserv
pocket
helix
ha
stalk
locat
trimer
head
region
therefor
within
realm
possibl
focu
immun
strategi
conserv
region
ha
protein
elicit
effect
antibodi
presum
cell
respons
case
emerg
influenza
virus
still
remain
mysteri
conserv
epitop
gener
high
level
popul
repeatedli
immun
infect
divers
viral
strain
factor
limit
influenza
vaccin
efficaci
human
includ
age
immunocompet
antibodi
level
previou
infect
immun
wherea
key
lesson
learn
use
anim
model
influenza
infect
studi
done
use
human
particip
invalu
describ
uniqu
often
complex
characterist
human
immun
respons
infect
immun
describ
central
find
obtain
human
influenza
challeng
studi
natur
infect
ex
vivo
character
human
immun
cell
tabl
figur
indic
question
remain
human
immun
respons
infect
effect
control
clearanc
influenza
infect
involv
compon
innat
adapt
immun
respons
mammal
cellular
innat
immun
system
act
defens
consist
multipot
hematopoiet
stem
cell
differenti
nk
cell
mast
cell
eosinophil
basophil
well
macrophag
neutrophil
dc
collect
known
phagocyt
cell
phagocyt
function
apc
engulf
digest
opson
pathogen
apoptot
cell
cell
essenti
act
scaveng
uptak
toxic
metabol
byproduct
produc
myriad
inflammatori
mediat
ideal
result
kill
virus
bacteria
parasit
howev
abund
inflamm
often
role
creat
immunopatholog
contribut
divers
inflammatori
diseas
includ
asthma
absenc
protect
immun
memori
innat
respons
limit
initi
viral
replic
adapt
immun
respons
develop
influenza
primarili
infect
epitheli
cell
line
respiratori
tract
infect
directli
phagoctyos
profession
innat
immun
cell
dc
macrophag
matur
respons
viral
stimuli
signal
infect
cell
activ
matur
dc
migrat
drain
ln
major
role
antigen
present
cell
influenza
infect
human
dc
result
decreas
dc
matur
suppress
type
ifn
product
season
virus
includ
elicit
weak
proinflammatori
cytokin
gene
express
human
dc
know
murin
model
influenza
contain
ligand
activ
sever
prr
signal
pathway
includ
retino
gene
recogn
dsrna
recogn
ssrna
type
type
iii
ifn
mediat
express
isg
via
jakstat
pathway
import
induct
antivir
respons
influenza
virus
stimul
pathway
dc
macrophag
lead
induct
potent
antivir
respons
includ
product
proinflammatori
cytokin
within
respiratori
tract
day
follow
infect
parallel
peak
viral
replic
mucu
product
diseas
symptom
level
peak
day
infect
symptom
begin
subsid
antimicrobi
peptid
collectin
defensin
cathelicidin
import
innat
effector
human
defens
influenza
infect
collectin
collagen
lectin
found
primarili
mucos
secret
includ
shown
inhibit
ha
activ
bind
oligosaccharid
manner
enhanc
activ
neutrophil
vitro
assay
murin
model
role
promot
viral
clearanc
lung
reduc
inflammatori
cytokin
role
human
influenza
infect
less
influenza
viru
impair
calcium
metabol
subsequ
calcium
deactiv
neutrophil
interestingli
protect
neutrophil
calcium
deactiv
preincub
viru
presum
inhibit
ha
activ
human
cathelicidin
human
cathelicidin
activ
form
found
divers
cell
type
includ
neutrophil
nk
cell
monocyt
b
cell
cell
mast
cell
well
epitheli
cell
line
lung
like
surfact
show
antivir
activ
influenza
reduc
viral
titer
vitro
studi
defensin
key
role
host
defens
act
primarili
disrupt
lipid
membran
lead
lysi
subsequ
death
bacteria
fungi
envelop
virus
two
class
defensin
first
describ
model
host
defens
bacteri
pathogen
type
found
respiratori
gastrointestin
tract
human
includ
found
high
concentr
within
neutrophil
granul
releas
within
lung
respons
proinflammatori
signal
infect
inflamm
vitro
act
chemokin
human
monocyt
induc
neutrophil
intern
influenza
vitro
moreov
may
role
directli
inactiv
influenza
viru
awsn
preincub
show
decreas
infect
vitro
manner
also
inhibit
influenza
viru
replic
via
modul
cellular
pathway
includ
pkc
pathway
heterogen
popul
monocyt
compris
blood
leukocyt
human
mous
role
control
pathogen
inflamm
character
function
cellular
subset
human
blood
monocyt
divid
three
popul
base
primarili
cell
surfac
express
lp
receptor
first
subgroup
consist
classic
monocyt
character
express
lack
express
monocyt
compris
blood
monocyt
resembl
murin
inflammatori
monocyt
second
subgroup
defin
high
express
releas
tnf
follow
lp
stimul
third
monocyt
subgroup
character
low
express
high
express
least
one
studi
shown
increas
number
blood
sepsi
patient
blood
monocyt
function
effici
produc
proinflammatori
cytokin
respons
virus
nucleic
acid
studi
examin
role
monocyt
influenza
infect
human
particularli
regard
specif
subset
mention
comparison
product
cell
cocultur
monocyt
show
monocyt
equival
monocyt
induc
greater
respons
influenza
antigen
vitro
human
dc
macrophag
treat
type
type
iii
ifn
prior
influenza
infect
result
potent
antivir
activ
decreas
viral
replic
among
dc
popul
pdc
found
produc
respons
high
dose
wherea
increas
number
total
cell
observ
blood
individu
decreas
blood
myeloid
dc
pdc
observ
defin
studi
respect
howev
increas
number
pdc
observ
nasal
secret
compar
healthi
control
within
cohort
protein
antagonist
antivir
respons
act
primarili
circumv
respons
review
ref
vivo
model
show
delet
result
viru
attenu
higher
level
ifn
type
ifn
antagon
result
inhibit
adapt
immun
interf
dc
matur
thu
abil
dc
activ
cell
protein
influenza
b
viru
inhibit
isgyl
import
host
antivir
effector
mechan
interact
domain
murin
model
provid
sever
clue
regard
actual
role
monocyt
innat
immun
respons
influenza
infect
vivo
recruit
inflammatori
monocyt
critic
host
defens
contribut
innat
immun
respons
well
downstream
adapt
respons
influenza
infect
mice
reduc
monocyt
increas
neutrophil
recruit
despit
higher
viral
lung
titer
one
model
infect
mice
protect
sever
pneumon
lung
recruit
tnf
dc
augment
cell
respons
least
one
murin
studi
suggest
pregnant
mice
increas
infiltr
neutrophil
macrophag
elev
proinflammatori
cytokin
level
despit
chang
viral
titer
lung
compar
nonpregn
anim
vitro
influenza
infect
murin
alveolar
epitheli
cell
result
monocyt
product
ligand
rant
monocyt
migrat
depend
express
although
murin
model
suggest
neutrophil
may
littl
role
mediat
viral
clearanc
type
interferon
gener
monocyt
follow
influenza
infect
may
necessari
limit
excess
neutrophil
infiltr
prevent
tissu
damag
caus
uncontrol
inflamm
addit
newli
describ
innat
lymphoid
cell
implic
role
airway
integr
follow
influenza
infect
thu
innat
immun
cell
particularli
monocyt
least
two
role
influenza
infect
boost
innat
immun
respons
produc
proinflammatori
cytokin
enhanc
cell
respons
howev
lack
clear
correspond
murin
human
monocyt
subset
made
applic
data
human
situat
difficult
highlight
need
specif
studi
focus
human
innat
immun
respons
rsv
influenza
infect
infant
neutrophil
recruit
upper
lower
airway
high
number
fatal
case
pandem
necrot
bronchiol
neutrophil
within
lung
infiltr
neutrophil
chemoattract
produc
bronchial
epitheli
cell
elev
earli
experiment
human
influenza
infect
increas
serum
individu
increas
level
bal
human
associ
infiltr
neutrophil
may
role
lung
injuri
develop
acut
respiratori
distress
syndrom
ex
vivo
influenza
infect
pbmc
shown
induc
apoptosi
neutrophil
peripher
blood
monocyt
influenza
infect
neutrophil
result
increas
hydrogen
peroxid
product
enhanc
surfac
express
fa
antigen
fasl
secret
fasl
supernat
interestingli
studi
show
influenza
infect
neutrophil
result
increas
intern
escherichia
coli
suggest
role
control
bacteri
secondari
infect
human
moreov
standard
chemotaxi
assay
experiment
influenza
infect
chemokin
receptor
express
ex
vivo
influenza
infect
demonstr
impair
chemotaxi
monocyt
granulocyt
still
although
studi
suggest
neutrophil
regul
recruit
human
influenza
infect
specif
protect
patholog
role
play
vivo
remain
unclear
nasopharyg
aspir
infant
infect
influenza
increas
level
proinflammatori
cytokin
compar
human
infant
level
higher
infant
sever
influenza
infect
character
hypox
bronchiol
variabl
studi
like
result
season
differ
observ
individu
infect
high
viral
load
detect
within
respiratori
secret
peripher
hypercytokinemia
sever
diseas
associ
macrophag
infiltr
lung
chemoattract
monocyt
macrophag
protein
monokin
induc
mig
found
elev
serum
individu
highest
infect
therefor
peripher
local
hypercytokinemia
like
contribut
enhanc
immunopathogenesi
influenza
diseas
although
differ
durat
viral
shed
children
hospit
infect
compar
infect
influenza
b
viru
children
influenza
exhibit
differ
serum
cytokin
profil
serum
level
similar
infect
level
increas
week
follow
influenza
b
infect
compar
influenza
infect
furthermor
serum
level
significantli
higher
acut
recoveri
phase
influenza
infect
influenza
strain
differ
also
observ
umbil
cord
blood
lymphocyt
treat
virus
influenza
b
viru
induc
less
rel
togeth
data
strongli
suggest
innat
cell
associ
respons
import
role
influenza
diseas
manifest
provid
protect
contribut
patholog
outcom
murin
studi
cite
clearli
demonstr
local
inflammatori
environ
dramat
differ
blood
profil
vast
major
experiment
data
human
restrict
blood
leukocyt
minim
emphasi
place
site
infect
lack
good
function
analysi
cell
human
studi
provid
correl
observ
result
signific
gap
knowledg
innat
immun
cell
affect
tissu
histori
respiratori
viru
challeng
studi
date
back
influenza
pandem
earli
studi
human
infect
influenza
identifi
princip
correl
protect
influenza
infect
antibodi
direct
ha
studi
review
ref
suggest
presenc
serum
antibodi
associ
protect
ill
less
frequent
observ
peopl
nab
subsequ
studi
show
protect
also
correl
develop
serum
mucos
igg
iga
protect
incomplet
individu
detect
nab
still
infect
antibodi
specif
na
shown
reduc
diseas
sever
restrict
viru
releas
infect
cell
enhanc
viral
clearanc
review
ref
addit
ha
na
antibodi
produc
np
matrix
protein
although
signific
respons
remain
unclear
cours
antigen
shift
antigen
drift
thwart
efficaci
serolog
memori
recent
circul
provid
modern
experi
natur
demonstr
import
antibodi
prior
infect
vaccin
even
prior
heterosubtyp
immun
larg
role
protect
antigen
variant
influenza
vaccin
studi
support
idea
adapt
immun
respons
occur
likewis
neutral
polyclon
antibodi
also
produc
individu
vaccin
season
influenza
well
natur
infect
compar
season
influenza
infect
prior
b
cell
epitop
conserv
conserv
within
surfac
viral
protein
ha
contain
sequenc
homolog
demonstr
mab
bind
sa
antigen
site
ha
furthermor
particular
antibodi
neutral
ha
activ
vitro
mice
show
reduc
viral
titer
challeng
neutral
antibodi
bind
expos
region
ha
surround
site
interfer
attach
sialic
acid
cell
surfac
therefor
gener
neutral
antibodi
elus
extern
viral
protein
expos
immun
pressur
univers
immun
conserv
ha
stalk
domain
promis
human
pbmc
includ
least
three
major
subset
dc
mdc
mdc
pdc
review
ref
dc
process
present
antigen
cell
therefor
import
role
regul
adapt
immun
respons
depend
local
cytokin
milieu
mdc
differenti
macrophag
dc
ie
epitheli
langerhan
cell
interstiti
dc
influenza
primarili
infect
epitheli
cell
line
respiratori
tract
dc
macrophag
particularli
import
effici
develop
adapt
immun
respons
activ
mdc
function
apc
activ
cell
hand
pdc
major
produc
type
ifn
upon
tlr
activ
respons
influenza
infect
vitro
human
dc
macrophag
undergo
matur
secret
type
ifn
induc
cell
prolifer
product
cellular
immun
respons
ctl
th
cell
import
viru
clearanc
murin
model
influenza
infect
mice
display
delay
viral
clearanc
relev
observ
remain
somewhat
controversi
human
regardless
mice
human
lung
contain
resid
respiratori
memori
cell
effect
kill
cell
human
cell
recogn
antigen
context
surfac
hla
molecul
gener
recogn
broad
rang
influenza
epitop
includ
structur
nonstructur
influenza
protein
approxim
cell
epitop
conserv
prior
circul
season
furthermor
intraepitheli
cell
mount
fast
effici
recal
respons
upon
viral
infect
immun
studi
human
shown
cell
respons
peak
within
week
symptom
onset
term
pandem
virus
individu
infect
shown
rapid
cell
recal
respons
earli
infect
ctl
respons
wane
time
likewis
vaccin
individu
natur
infect
cell
respons
increas
twofold
earli
infect
memori
cell
isol
pbmc
healthi
individu
also
protein
heterolog
virus
includ
immunocompromis
patient
last
antibodi
memori
respons
follow
natur
infect
furthermor
ctl
isol
individu
memori
phenotyp
respond
robustli
peptid
pool
cell
suggest
cell
may
provid
level
protect
conserv
epitop
although
nonconserv
region
viru
may
effect
escap
recognit
cell
major
cell
respons
elicit
conserv
intern
viral
protein
gener
much
interest
vaccin
therapeut
strategi
involv
immun
frequent
neglect
popul
lymphocyt
cell
compris
cell
blood
human
major
cell
cell
consid
major
cell
subset
review
ref
vitro
studi
suggest
activ
human
cell
may
role
antivir
respons
kill
macrophag
produc
high
level
particular
neonat
known
compromis
cellular
immun
respons
repres
import
target
popul
influenza
immun
despit
critic
target
popul
rel
neonat
model
respiratori
infect
ethic
reason
appropri
difficult
acquir
data
human
neonat
case
rsv
infect
murin
neonat
model
suggest
age
primari
viral
infect
determin
immunopatholog
secondari
viral
infect
rsv
infect
younger
murin
neonat
day
develop
immun
respons
character
increas
eosinophil
cell
recruit
lung
enhanc
airway
higher
level
upon
reinfect
week
later
wherea
older
mice
week
develop
immun
respons
character
decreas
cell
eosinophil
recruit
lung
upon
reinfect
likewis
neonat
mous
model
influenza
viru
show
earli
infect
associ
decreas
cell
recruit
function
enhanc
airway
inflamm
studi
highlight
import
concept
wherebi
infect
earli
result
protect
immun
immunopathogenesi
consist
defect
adapt
immun
rsv
influenza
infect
infant
cell
nk
cell
found
upper
lower
airway
contrast
observ
infiltr
lymphocyt
adult
influenza
sar
cov
infect
moreov
fatal
case
increas
number
cell
granzym
b
cell
lung
observ
may
repres
correl
higher
level
viral
antigen
may
indic
pathogen
role
exuber
cell
respons
hand
elderli
shown
reduc
ctl
activ
compar
younger
individu
neg
impact
immun
efficaci
howev
prevaccin
cell
respons
correl
postvaccin
antibodi
titer
elderli
also
decreas
antibodi
respons
follow
vaccin
cell
respons
may
provid
better
correl
vaccin
efficaci
elderli
popul
interestingli
unstimul
memori
cell
older
individu
higher
state
differenti
younger
individu
shown
fewer
senesc
cell
character
killer
cell
receptor
subfamili
g
member
associ
robust
antibodi
respons
follow
tiv
deliveri
immunodomin
hierarchi
individu
often
report
direct
primarili
conserv
influenza
gilgfvftl
howev
studi
suggest
although
cell
respons
conserv
individu
may
strictli
immunodomin
greater
respons
observ
intern
np
polymeras
subunit
protein
individu
term
hla
present
influenza
peptid
ctl
respons
character
express
tcr
use
individu
ctl
domin
cell
respond
vitro
influenza
exposur
contrast
cord
blood
infant
thu
prior
influenza
exposur
character
cell
respons
less
depend
presenc
cell
popul
therefor
matur
ctl
respons
upon
subsequ
influenza
infect
like
relat
effect
clearanc
viral
infect
import
implic
therapeut
intervent
although
children
beyond
infanc
consid
influenza
infect
ie
children
underli
diseas
asthma
sickl
cell
diseas
receiv
solid
organ
transplant
signific
increas
serum
nab
cell
respons
children
system
lupu
erythematosu
unabl
mount
signific
cell
respons
follow
tiv
immun
find
suggest
pathogenesi
respiratori
viral
infect
infant
may
associ
absenc
immunolog
memori
failur
develop
appropri
cell
respons
undoubtedli
host
genet
role
outcom
mani
infecti
diseas
includ
influenza
mous
model
provid
clue
regard
role
host
genet
compon
inflammatori
respons
respiratori
tract
briefli
studi
found
patholog
alter
depend
inbr
mous
strain
use
infect
genet
background
host
also
control
cumul
maxim
viral
titer
underscor
import
limit
viral
replic
earli
influenza
infect
human
certain
popul
worldwid
found
prone
sever
diseas
influenza
infect
instanc
aborigin
peopl
sever
ill
increas
mortal
pandem
compar
descent
import
note
howev
poor
socioeconom
condit
metabol
diseas
diabet
common
indigen
popul
may
contribut
diseas
moreov
hla
allel
propos
role
influenza
infect
differenti
ctl
respons
exist
individu
vari
hla
allel
gene
polymorph
locat
human
chromosom
also
determin
associ
sever
pneumonia
infect
interestingli
two
snp
map
gene
protein
encod
involv
phagocytosi
clearanc
immun
complex
express
surfac
phagocyt
cell
protein
encod
critic
factor
involv
complement
activ
notabl
presenc
antibodi
subsequ
format
immun
complement
activ
lung
patient
sever
influenza
infect
associ
sever
diseas
follow
influenza
infect
recent
system
biolog
strategi
emerg
improv
vaccin
efficaci
measur
express
pattern
expos
protect
molecular
signatur
follow
immun
natur
infect
confirm
vitro
mous
studi
suggest
mbl
neutral
influenza
human
polymorph
identifi
within
associ
poor
antibodi
respons
influenza
vaccin
although
mbl
defici
observ
influenc
outcom
sever
respiratori
diseas
includ
pneumococcu
infect
tuberculosi
sar
cov
review
ref
obviou
role
infect
individu
studi
highlight
involv
host
genet
develop
enhanc
diseas
although
like
repres
small
fraction
potenti
regulatori
host
genet
element
studi
innat
adapt
immun
respons
influenza
viru
infect
restrict
primarili
anim
model
diseas
inflamm
immunolog
tool
becom
sophist
emphasi
place
human
immunolog
oppos
reli
sole
anim
infect
model
moreov
vast
major
experiment
data
human
restrict
blood
leukocyt
minim
emphasi
place
innat
immun
respons
particularli
site
infect
result
limit
scientif
knowledg
regard
specif
role
immun
cell
affect
tissu
understand
innat
respons
particular
critic
appreci
earli
determin
pathogen
diseas
outcom
influenza
infect
